A study from Ann & Robert H. Lurie Children’s Hospital of Chicago has shown that prenatal diagnosis, or diagnosis before a baby is born, is associated with earlier surgery for babies with congenital heart defects, the most common birth defects affecting nearly 1% of all live births.
CC-98633 by Bristol-Myers Squibb for Relapsed Multiple Myeloma: Likelihood of Approval
CC-98633 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Relapsed Multiple Myeloma.
February 21, 2024